Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université de Montréal

$28,000.00

Understanding Biomaterials Stimulated Organ Regeneration

FY 2017-18

Summary
Many biomaterials being tested or used clinically are plastic-based with promising short-term results in animals and early clinical trials. Longer term results, however, can be sub-optimal to harmful. Biomaterials based on the extracellular matrix (ECM) are now being tested for stimulating regeneration but are they actually safer as believed, as there have been reported fatalities. My long-term goal is to understand how biomaterials and cells interact, to identify the ""good"" biomaterials that promote safe regeneration and avoid ""bad"" ones leading to problems. Extracellular vesicles (EVs) are key components in intercellular communication. They contain a wide range of cargo (mRNA, microRNA, proteins, signaling molecules and lipids) that modulate regeneration and have been proposed as cell-free therapeutic agents. However, there is no information on biomaterials-induced EV production and regeneration. I will test the hypothesis that EV are effectors for biomaterials-stimulated regeneration and that their pattern of expression and cargo will allow us to distinguish the good versus bad, or neutral biomaterials in terms of long-term outcomes. I will use the cornea as an experimental model as there is a long history of corneal implants made from a range of biomaterials with documented long-term clinical outcomes that can be used to aid in producing the EV barcodes (size, content, surface markers). I will begin with biomaterials in the form of implants that are designed as pro-regeneration scaffolds. We will fabricate implants made from methacrylates (poor regeneration) to blends of pHEMA/collagen (mediocre regeneration) to recombinant human collagen (excellent regeneration) and new materials based on mimetic analogs of collagen. Polyethylene glycol (PEG) hydrogels have been shown to be passive, and biocompatible by virtue of their inertness. A set of PEG-based scaffolds will be fabricated where we will add incremental amounts of collagen and collagen-like peptides until these scaffolds promote optimal growth of corneal and nerve cells, but not activate antigen presenting dendritic cells, in order to examine the changes in EV profile with increasing cell-friendliness. We will define EV expression based on their sub-type (microvesicles/microparticles/ectosomes; exosomes; or apoptotic bodies) and their protein and mRNA cargoes during cell-material interactions in vitro, by seeding cells onto materials as 2D constructs and compare their interactions as implants in 3D constructed corneal equivalents that we have characterized very well. These interactions will be observed in real time by confocal microscopy using two-photon confocal microscopy. In vitro results will be corelated with in vivo implantation. Our will be a barcode of EVs and contents that will point to biomaterials promoting successful regeneration versus those that give poor regeneration or an adverse reaction.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2017-05410
Name nom
Griffith, May
Department département
Ophtalmologie - Ophtalmologie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
5
Application title
Understanding Biomaterials Stimulated Organ Regeneration
Keyword
NSERC
Application summary
Many biomaterials being tested or used clinically are plastic-based with promising short-term results in animals and early clinical trials. Longer term results, however, can be sub-optimal to harmful. Biomaterials based on the extracellular matrix (ECM) are now being tested for stimulating regeneration but are they actually safer as believed, as there have been reported fatalities. My long-term goal is to understand how biomaterials and cells interact, to identify the ""good"" biomaterials that promote safe regeneration and avoid ""bad"" ones leading to problems. Extracellular vesicles (EVs) are key components in intercellular communication. They contain a wide range of cargo (mRNA, microRNA, proteins, signaling molecules and lipids) that modulate regeneration and have been proposed as cell-free therapeutic agents. However, there is no information on biomaterials-induced EV production and regeneration. I will test the hypothesis that EV are effectors for biomaterials-stimulated regeneration and that their pattern of expression and cargo will allow us to distinguish the good versus bad, or neutral biomaterials in terms of long-term outcomes. I will use the cornea as an experimental model as there is a long history of corneal implants made from a range of biomaterials with documented long-term clinical outcomes that can be used to aid in producing the EV barcodes (size, content, surface markers). I will begin with biomaterials in the form of implants that are designed as pro-regeneration scaffolds. We will fabricate implants made from methacrylates (poor regeneration) to blends of pHEMA/collagen (mediocre regeneration) to recombinant human collagen (excellent regeneration) and new materials based on mimetic analogs of collagen. Polyethylene glycol (PEG) hydrogels have been shown to be passive, and biocompatible by virtue of their inertness. A set of PEG-based scaffolds will be fabricated where we will add incremental amounts of collagen and collagen-like peptides until these scaffolds promote optimal growth of corneal and nerve cells, but not activate antigen presenting dendritic cells, in order to examine the changes in EV profile with increasing cell-friendliness. We will define EV expression based on their sub-type (microvesicles/microparticles/ectosomes; exosomes; or apoptotic bodies) and their protein and mRNA cargoes during cell-material interactions in vitro, by seeding cells onto materials as 2D constructs and compare their interactions as implants in 3D constructed corneal equivalents that we have characterized very well. These interactions will be observed in real time by confocal microscopy using two-photon confocal microscopy. In vitro results will be corelated with in vivo implantation. Our will be a barcode of EVs and contents that will point to biomaterials promoting successful regeneration versus those that give poor regeneration or an adverse reaction.